The risk of prion contamination through the transfusion of cellular products;Le risque de contamination par le prion lors de la transfusion de produits sanguins labiles

Transfusion Clinique et Biologique

Volumn 14, Issue 1, 2007, Pages 25-34

  Lefrère, Jean Jacques ^a,b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

cellular products; Prion; Transfusion safety

Indexed keywords

BLOOD TRANSFUSION; CELL TRANSFER; CREUTZFELDT JAKOB DISEASE; HUMAN; INFECTION RISK; PRION; SCREENING; SHORT SURVEY;

BLOOD COMPONENT TRANSFUSION; CREUTZFELDT-JAKOB SYNDROME; FRANCE; GREAT BRITAIN; HUMANS; PRION DISEASES; RISK FACTORS; SAFETY;

EID: 34249866853     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2007.04.007     Document Type: Short Survey

References (35)

1. Will R.G., Ironside J.W., Zeidler M., et al. A new variant of CJD in the UK. Lancet 347 (1996) 921-925
2. Zeidler M., Stewart G.E., Barraclough C.R., et al. New variant Creutzfeld-Jacob disease: neurological features and diagnostic tests. Lancet 350 (1997) 903-907
3. Bishop M.T., Hart P., Aitchison L., et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5 (2006) 393-398
4. Wadsworth J.D., Joiner S., Hill A.F., et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358 (2001) 171-180
5. Alperovitch A., and Will R.G. Predicting the size of the vCJD epidemic in France. CR Biol 325 (2002) 33-36
6. Chadeau-Hyam M., Tard A., Bird S., et al. Estimation of the exposure of the French population to the BSE agent: comparison of the 1980-95 consumption of beef products containing mechanically recovered meat in France and the UK, by birth cohort and gender. Stat Methods Med Res 12 (2003) 247-260
7. Cooper J.D., and Bird S.M. UK bovine carcass meat consumed as burgers, sausages and other meat products: by birth cohort and gender. J Cancer Epidemiol Prev 7 (2002) 49-52
8. Chadeau-Hyam M., and Alperovitch A. Risk of variant Creutzfeldt-Jakob disease in France. Int J Epidemiol 34 (2005) 46-52
9. Brandel J.P., Salomon D., and Alpérovitch A. Epidémiologie de la variante de la maladie de Creutzfeld-Jacob en France. Transfus Clin Biol 13 (2006) 304-306
10. Ghani A.C., Ferguson N.M., Donnelly C.A., et al. Predicted vCJD mortality in Great Britain. Nature 406 (2000) 583-584
11. Hilton D., Ghani A., Conyers L., et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203 (2004) 733-739
12. Ironside J.W., Bishop M.T., Connolly K., et al. Variant Creutzfeldt-Jacob disease: prion protein genotype analysis of positive appendix samples from a retrospective prevalence study. BMJ 332 (2006) 1186-1188
13. Houston F., Foster J.D., Chong A., Hunter N., et al. Transmission of BSE by blood transfusion in sheep. Lancet 356 (2000) 999-1000
14. Martin M., Legras J.-F., Pouchol E., et al. Évaluation du risque transfusionnel vis-à-vis de la variante de la maladie de Creutzfeld-Jacob en France. Transfus Clin Biol 13 (2006) 298-303
15. Hunter N., Foster J., Chong A., et al. Transmission of prion diseases by blood transfusion. J Gen Virol 83 (2002) 2897-2905
16. Saa P., Castilla J., and Soto C. Presymptomatic detection of prions in blood. Science 313 (2006) 92-94
17. Head M.W., Ritchie D., Smith N., et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 164 (2004) 143-153
18. Hewitt P.E., Llewelyn C.A., Mackenzie J., et al. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 91 (2006) 221-230
19. Llewelyn C.A., Hewitt P.A., Knight R.S.G., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
20. Health Protection Agency. New case of transfusion-associated variant-CJD. CDR Weekly 2006;16(6).
21. Peden A.H., Head M.W., Ritchie D.L., et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 (2004) 527-529
22. Health protection agency. Fourth case of variant CJD associated with blood transfusion (on line), 18 January 2007.
23. Gregori L., McCombie N., Palmer D., et al. Effectiveness of leucodepletion for removal of infectivity of TSEs from blood. Lancet 364 (2004) 529-531
24. Herzog C., Sales N., Etchegaray N., et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 363 (2004) 422-428
25. Lasmezas C.I., Fournier J.G., Nouvel V., et al. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc Natl Acad Sci U S A 98 (2001) 4142-4147
26. Brown P., Rohwer R.G., Dunstan B.C., et al. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 38 (1998) 810-816
27. Brown P., Cervenakova L., McShane L.M., et al. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 39 (1999) 1169-1178
28. Brown P. Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy. Vox Sang 89 (2005) 63-70
29. Gregori L., Lambert B.C., Gurgel P.V., et al. Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands. Transfusion 46 (2006) 1152-1161
30. Cervenakova L., Yakovleva O., McKenzie C., et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 43 (2003) 1687-1694
31. Sowemimo-Coker S., Kascsak R., Kim A., et al. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter. Transfusion 45 (2005) 1839-1844
32. Sowemimo-Coker S.O., Pesci S., Andrade F., et al. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates. Vox Sang 90 (2006) 265-275
33. Castilla J., Saa P., and Soto C. Detection of prions in blood. Nat Med 11 (2005) 982-985
34. Fagge T., Barclay G.R., MacGregor I., et al. Variation in concentration of prion protein in the peripheral blood of patients with variant and sporadic Creutzfeldt-Jakob disease detected by dissociation enhanced lanthanide fluoroimmunoassay and flow cytometry. Transfusion 45 (2005) 504-513
35. Lefrère J.J. The BOTIA project («Blood and Organ Transmissible Infectious Agents»): a European collection of blood samples and an observatory of agents transmitted by blood transfusion or organ transplantation. Transfus Clin Biol 12 (2005) 93-94